Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosuvastatin anti-inflammatory effects in psoriasis
2009-014364-18Phase 3Terminated
- Sponsor
- Policlinico Gemelli
- Start
- Jul 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of rosuvastatin in psoriasis, sponsored by Policlinico Gemelli. Primary endpoint: Change in inflammatory markers after 30 days of rosuvastatin. Started Jul 2009; status: terminated.
02
Drugs
rosuvastatin
03
Conditions
psoriasis
Beyond the preview
Go deeper on 2009-014364-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-014364-18.